Analysts expect ChronoScale Corporation to report a consensus revenue of $18.10 million and a loss per share of $0.02 for Q3 2026. The current stock price of $14.77 sits significantly below the average analyst price target of $28.50, reflecting high expectations for its recent business transformation.
Investors are primarily focused on the company’s progress toward achieving its $1 billion annualized revenue run-rate target by calendar Q3 2027.
This follow-through is critical after ChronoScale completed the sale of its legacy exoskeleton business on September 30, 2026, to become a pure-play AI infrastructure provider. Market participants are specifically looking for execution updates on the 50 MW AI compute deployment with Microsoft and the ramp-up of its NVIDIA GPU-accelerated cloud platform.